Quintiles Transitional Holdings Inc. Forecasted to Earn FY2017 Earnings of $4.61 Per Share (Q)
Quintiles Transitional Holdings Inc. (NYSE:Q) – Investment analysts at William Blair boosted their FY2017 EPS estimates for Quintiles Transitional Holdings in a report issued on Friday. William Blair analyst J. Kreger now anticipates that the medical research company will earn $4.61 per share for the year, up from their previous estimate of $4.57. William Blair currently has a “Outperform” rating and a $93.42 target price on the stock. William Blair also issued estimates for Quintiles Transitional Holdings’ Q4 2017 earnings at $1.33 EPS, Q2 2018 earnings at $1.27 EPS, Q3 2018 earnings at $1.37 EPS, Q4 2018 earnings at $1.53 EPS, FY2018 earnings at $5.36 EPS, FY2019 earnings at $6.08 EPS and FY2020 earnings at $6.90 EPS.
Quintiles Transitional Holdings (NYSE:Q) last posted its quarterly earnings results on Thursday, October 26th. The medical research company reported $1.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.14 by $0.05. Quintiles Transitional Holdings had a net margin of 0.58% and a return on equity of 12.60%. The business had revenue of $2.02 billion during the quarter, compared to analyst estimates of $2.01 billion. During the same period in the prior year, the business posted $1.00 earnings per share. The company’s revenue was up 77.6% on a year-over-year basis.
Q has been the topic of a number of other reports. Barclays PLC set a $100.00 target price on shares of Quintiles Transitional Holdings and gave the stock a “buy” rating in a report on Friday, August 4th. Zacks Investment Research downgraded shares of Quintiles Transitional Holdings from a “buy” rating to a “hold” rating in a report on Tuesday, August 1st. KeyCorp restated a “buy” rating and issued a $100.00 target price on shares of Quintiles Transitional Holdings in a report on Sunday, September 24th. Jefferies Group LLC restated a “hold” rating and issued a $94.00 target price on shares of Quintiles Transitional Holdings in a report on Friday, August 4th. Finally, Stifel Nicolaus restated a “hold” rating and issued a $92.00 target price (up from $87.00) on shares of Quintiles Transitional Holdings in a report on Friday, August 4th. Nine equities research analysts have rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $99.41.
Shares of Quintiles Transitional Holdings (NYSE Q) opened at 107.66 on Monday. The stock has a market capitalization of $23.31 billion, a price-to-earnings ratio of 312.06 and a beta of 0.62. The firm’s 50-day moving average is $97.62 and its 200 day moving average is $90.51. Quintiles Transitional Holdings has a 52-week low of $70.10 and a 52-week high of $108.43.
A number of institutional investors have recently added to or reduced their stakes in Q. Fiduciary Trust Co. purchased a new stake in Quintiles Transitional Holdings in the 2nd quarter valued at about $105,000. GWM Advisors LLC purchased a new stake in Quintiles Transitional Holdings in the 2nd quarter valued at about $122,000. Korea Investment CORP lifted its position in shares of Quintiles Transitional Holdings by 142.5% in the 2nd quarter. Korea Investment CORP now owns 1,370 shares of the medical research company’s stock worth $123,000 after purchasing an additional 805 shares during the period. Citigroup Inc. lifted its position in shares of Quintiles Transitional Holdings by 15.5% in the 2nd quarter. Citigroup Inc. now owns 1,858 shares of the medical research company’s stock worth $167,000 after purchasing an additional 250 shares during the period. Finally, Bbva Compass Bancshares Inc. lifted its position in shares of Quintiles Transitional Holdings by 4.2% in the 2nd quarter. Bbva Compass Bancshares Inc. now owns 2,204 shares of the medical research company’s stock worth $197,000 after purchasing an additional 88 shares during the period. 93.27% of the stock is owned by institutional investors.
In other Quintiles Transitional Holdings news, major shareholder Cpp Investment Board Private H sold 6,748,026 shares of the business’s stock in a transaction dated Tuesday, September 19th. The shares were sold at an average price of $94.87, for a total value of $640,185,226.62. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Ari Bousbib sold 92,160 shares of the business’s stock in a transaction dated Monday, August 7th. The shares were sold at an average price of $90.35, for a total transaction of $8,326,656.00. Following the completion of the sale, the insider now directly owns 1,082,919 shares of the company’s stock, valued at $97,841,731.65. The disclosure for this sale can be found here. Over the last three months, insiders sold 14,208,382 shares of company stock valued at $1,362,839,475. 6.40% of the stock is owned by corporate insiders.
About Quintiles Transitional Holdings
Quintiles IMS Holdings, Inc, formerly Quintiles Transnational Holdings Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.
Receive News & Ratings for Quintiles Transitional Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quintiles Transitional Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.